Intended for healthcare professionals


US doctor warns of misuse of prescribed stimulants

BMJ 2003; 326 doi: (Published 11 January 2003) Cite this as: BMJ 2003;326:67
  1. Charles Marwick
  1. Washington, DC

    Europe is being targeted by the drugs industry as the next major market for increasing the use of stimulant drugs such as methylphenidate (Ritalin) and dexamfetamine, a Californian doctor specialising in behavioural paediatrics warned at a recent meeting of the President's Bioethics Council.

    Dr Lawrence Diller has become known in the United States as a critic of the inappropriate use of stimulants such as methylphenidate for the management of children with attention deficit hyperactivity disorder. Besides its therapeutic uses methylphenidate has also attracted non-therapeutic uses: pacifying unruly children, enhancing performance, and, as Dr Diller …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription